News Industry News Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use May 07, 2019
News Industry News Corindus Equips the World’s First Fully Robotic Catheterization Laboratory May 07, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Industry News Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System May 06, 2019
News Industry News FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis May 06, 2019
News Features Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients? Caitlin E. Cox May 01, 2019
News Industry News Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial April 19, 2019
Presentation Fellows 2019 Peripheral Case Potpourri: Head to Toe Presenter: Sahil Parikh April 14, 2019
Presentation ARCH 2019 Alternative access for complex peripheral intervention Presenter: Bryan D. Cogar April 12, 2019
News Conference News ACC 2019 Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY Yael L. Maxwell March 27, 2019
Presentation SIF 2019 Tips and Tricks for Triumphant Transradial Access Presenter: Binita Shah March 27, 2019
News Conference News CRT 2019 Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy L.A. McKeown March 06, 2019
News Industry News Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study March 05, 2019
News Daily News A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex L.A. McKeown March 01, 2019
News Daily News No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds L.A. McKeown March 01, 2019
News Daily News Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons L.A. McKeown February 19, 2019